SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Mannatech, Inc. engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L. Caster in November 1993 and is headquartered in Flower Mound, TX.

Mannatech Inc

Mannatech ($MTEX) is experiencing heightened interest following a substantial surge in trading volume, with community members aggressively speculating on a potential low-float short squeeze. Discussions are centered on its micro-cap status and the possibility of a multi-day parabolic run, drawing comparisons to other recent volatile movers, though some express caution regarding a potential pump and dump.

Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.

Ekso Bionics Holdings Inc

Ekso Bionics is trending following a proposed merger with Applied Digital's cloud computing business to create ChronoScale, an accelerated GPU compute platform for AI workloads. This strategic shift from medical hardware to the rapidly expanding AI infrastructure sector is generating significant community discussion, with many envisioning a complete valuation framework change and others cautious about the implications for existing shareholders.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is experiencing significant momentum driven by positive preliminary Phase 3 trial data, demonstrating a substantial reduction in breast cancer recurrence rates. This, coupled with an extended insider share lock-up signaling strong management confidence and extremely high short interest borrow rates, has the community actively discussing a potential short squeeze and long-term valuation prospects for this low-float biotech.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending amidst significant debate, driven by the positive news of Duchenne muscular dystrophy (DMD) being added to the U.S. Recommended Uniform Screening Panel (RUSP), which is seen as a key long-term catalyst for its Elevidys gene therapy. However, the community remains divided, with strong bulls arguing for its extreme undervaluation given approved therapies and its RNAi pipeline, while bears point to past management decisions, financial health concerns, and intensifying competition from other emerging DMD treatments.

Global X Funds - Global X Uranium ETF

Global X Uranium ETF

The Global X Uranium ETF (URA) is trending as the exponential power demands of AI accelerate the urgent need for stable nuclear energy, positioning it as critical infrastructure. The community is actively discussing a structural uranium supply deficit, rising spot prices, and significant accumulation by investment vehicles, driving strong expectations for a major sector rally.

The Clorox Co. engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States. The Household segments consists of bags and wraps, grilling products and cat litter marketed and sold in the United States. The Lifestyle segment refers to food, natural personal care products and water-filtration products marketed and sold in the United States. The International segment covers products sold outside the United States, excluding natural personal care products. The company was founded by Edward Hughes, Charles Husband, William Hussey, Rufus Myers, and Archibald Taft on May 3, 1913 and is headquartered in Oakland, CA.

Clorox Co.

Clorox is trending due to a strong quarterly earnings beat, surpassing revenue and EPS expectations, and raising its full-year guidance. The positive news signals an accelerated recovery from its recent cyberattack, with the company rebuilding inventories and restoring distribution ahead of schedule. Community discussion highlights renewed interest in this defensive stock, with some viewing it as a turnaround play amidst broader market volatility and a potential rotation into dividend-paying assets.

Didi Global, Inc. engages in the operation of mobility platforms that provides ride hailing and other related services. It operates through the following segments: China Mobility, International, and Other Initiative. The China Mobility segment consists of ride hailing, taxi hailing, chauffeur and hitch services. The International segment includes ride hailing and food delivery services in international markets, outside of China. The Other Initiatives segment mainly consists of bike and e-bike sharing, certain auto solutions, intra-city freight, community group buying, autonomous driving, and financial services. The company was founded by Wei Cheng, Qing Liu, Bo Zhang and Rui Wu on January 11, 2013 and is headquartered Beijing, China.

DiDi Global Inc - ADR

DiDi Global Inc. is trending as its major class-action lawsuit nears final resolution, fueling community anticipation for an imminent Hong Kong relisting. While some investors are debating the impact of increased international expansion costs, optimism persists regarding the company's long-term growth trajectory, particularly its aggressive advancements in autonomous driving and robotaxi technology.

Cameco Corp. engages in the provision of uranium. It operates through the Uranium and Fuel Services segments. The Uranium segment is involved in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment deals with the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. The company was founded in 1988 and is headquartered in Saskatoon, Canada.

Cameco Corp.

Cameco is actively discussed following a significant strategic partnership with the U.S. government and Brookfield to accelerate nuclear reactor deployment, a move seen as critical for powering future AI data centers. The community is highly bullish on Cameco's role as a leading uranium supplier amidst tightening global supply and increasing demand for nuclear energy.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML is trending following a mixed earnings report that showcased strong orders driven by the ongoing AI boom, alongside a cautious outlook for declining China sales. Community discussion is focused on renewed US geopolitical pressure on its China business and the enduring strength of ASML's indispensable monopoly in advanced chipmaking equipment, crucial for the AI revolution.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is generating significant conversation following the completion of its pension reversion, which is strengthening its balance sheet and fueling its strategic pivot into pharmaceutical and battery manufacturing. The community is actively discussing the potential for major government contracts and the company's role in bolstering domestic supply chains, leading to widespread anticipation of a significant re-rating and possible short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers. Its lead candidates are the oral gamma secretase inhibitor, AL102, for desmoid tumors, and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. The company was founded on June 5, 1987 and is headquartered in Monmouth Junction, NJ.

ADXS
Advaxis, Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest ADXS News

ADXSAdvaxis, Inc.